Key takeaways

  • In England the scheme is confirmed (Aug 2025) and traffic-light tiers are proposed, but NOTHING is in force yet. The red-tier consultation was still pending as of July 2026, so rollout is realistically 2027+
  • In Scotland the Non-surgical Procedures Act 2026 is law. Council licences for designated procedures are required from 6 September 2027, and fillers are restricted to healthcare professionals in HIS-registered premises
  • Wales has licensed special procedures (SPMU/tattooing, piercing, electrolysis, acupuncture) since Nov 2024; injectables are NOT included
  • Northern Ireland has no scheme and no under-18 ban so far
  • Preparation beats prediction. Regulated qualifications, insurance, premises records and complications training are common to every proposed standard

This is the page we wish had existed when the sector started saying “licensing is coming” in 2022: every milestone dated, every claim sourced, all four UK nations, updated as the rules actually move. Bookmark it; the date at the top tells you when a clinician last reviewed it.

The one-paragraph status (10 July 2026)

England: scheme confirmed in principle, nothing in force, key consultation still pending, and no licence exists today. Scotland: primary legislation passed (Royal Assent May 2026); council licences due from 6 September 2027 under a separate 2026 Order; the Act’s healthcare-professional premises restriction is expected no earlier than the same date. Wales: special-procedures licensing live since November 2024, but it does not cover injectables. Northern Ireland: no scheme and no under-18 statute yet; watch this space. For what each nation has legislated and what it means for training, see what UK aesthetics regulation actually requires.

England’s traffic-light scheme

What’s confirmed

Using powers under section 180 of the Health and Care Act 2022, the government’s August 2025 consultation response confirmed: two licences (practitioner and premises) administered by local authorities; procedures sorted into three risk tiers; minimum standards for training, insurance, hygiene and safety; and under-18 restrictions extending the approach of the 2021 toxin-and-fillers ban.

The proposed tiers

These are the 2023 consultation lists; the final lists are still to come.

TierExamples (proposed)Who may perform (proposed)
Green (lower risk)Microneedling, mesotherapy (no-needle), IPL/LED, superficial peels, SPMU/microblading, non-ablative laser hair removalAny licensed practitioner meeting standards
Amber (medium risk)Botulinum toxin, dermal fillers, biorevitalisation, PRP, vitamin injections, microsclerotherapy, weight-loss injections, HIFU/RF, medium-depth peels, plasma fibroblastRegulated healthcare professionals independently; others only with oversight by a named regulated healthcare professional (oversight model undefined)
Red (highest risk)Breast/buttock/genital augmentation with fillers or fat (“liquid BBL”), intimate-area injectables, all thread lifts, hair restoration surgery, deep phenol peels, extensive ablative CO₂, IV infusionsSuitably qualified regulated healthcare professionals working for CQC-registered providers only

Timeline of record

DateMilestone
1 Oct 2021Under-18 toxin/filler ban in force (England only)
28 Apr 2022Health and Care Act 2022 (s.180 licensing power)
Sep–Oct 2023First consultation (~11,800 responses; majority supportive)
6–7 Aug 2025Government response: tiers confirmed; “Wild West” press framing; red-tier consultation promised “early 2026”
Nov 2025Lords written answer revises red-tier consultation to “spring 2026”
18 Feb 2026Women and Equalities Committee: “no further progress”; demands immediate liquid-BBL ban and green/amber licensing this Parliament
10 Jul 2026This review: red-tier consultation not yet published on gov.uk
Expected 2026–27Red-tier CQC regulations → local-authority licensing consultation → secondary legislation → rollout (sector estimates: applications/inspections from 2027)

What English practitioners should do now

  • Hold or start regulated qualifications for your modality (Level 4/5 laser, Level 7 injectables); every proposed standard references accredited training.
  • Get complications training documented; insurance and safety protocols are named licence standards.
  • Put premises basics in order (records, consent, hygiene, waste, emergency kit). The premises licence will inspect exactly these.
  • If your service touches the proposed red tier (threads, extensive ablative CO₂, hair restoration surgery), plan for CQC registration rather than hoping the list changes.

Scotland, from consultation to statute

Scotland skipped the waiting and legislated. The Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 (introduced Oct 2025, passed 17 Mar 2026, Royal Assent 12 May 2026) creates a two-tier regime:

  • Schedule 1 procedures, the lower-risk skin-piercing and skin-penetrating work (microneedling, certain peels, cryolipolysis, laser treatments), need a local-authority licence under the Civic Government (Scotland) Act framework. Licences will be required from 6 September 2027 under the Civic Government (Scotland) Act 1982 (Licensing of Non-surgical Procedures) Order 2026, with transitional cover for early applicants.
  • Everything else in scope, including dermal fillers and stronger peels, will be restricted to healthcare professionals providing or managing the service from Healthcare Improvement Scotland–registered premises. That section is not yet in force; commencement can be no earlier than 6 September 2027.

Add the existing layer: HIS registration has covered doctor/nurse/dentist-led independent clinics since 2016, with pharmacists added June 2024 (offence for unregistered provision since June 2025). The Act also bans in-scope procedures for under-18s and empowers ministers to set training and qualification requirements. That last provision is the one most likely to define Scottish entry standards.

Wales moved first

Since 29 November 2024, Part 4 of the Public Health (Wales) Act 2017 licenses special procedures: tattooing (including SPMU and microblading), body piercing, electrolysis and acupuncture (including dry needling). Practitioner licences, approved premises, an accredited infection-prevention qualification and a public register make it the UK’s first mandatory scheme of its kind. Botox and fillers are not covered; Welsh councils have publicly urged their inclusion, and the s.180 architecture could extend to Wales later. There is no Welsh under-18 toxin/filler ban.

Northern Ireland, the quiet nation

No dedicated scheme, no under-18 statute; councils register skin piercing under general law and RQIA regulates defined clinical settings. Council-level discussion continued through 2025–26 without legislation. Practitioners banking on NI’s quiet being permanent are making a bet we wouldn’t.

Adjacent enforcement that already bites

  • Remote prescribing for cosmetics is banned by the GDC (2013), GMC (2016), GPhC guidance, and the NMC explicitly from 1 June 2025. The ban covers follow-ups and emergency-kit items too.
  • POM advertising rules mean toxin and weight-loss medicines cannot be advertised to the public; MHRA/ASA/GPhC enforcement ran hot through 2025 and was reaffirmed 18 June 2026.
  • On unlicensed product, the 2025 botulism outbreak (41 cases) and the first illicit GLP-1 factory raid made sourcing evidence a survival trait.
  • Under CAP/BCAP rules, cosmetic-procedure ads must not target under-18s (UK-wide since May 2022).

Our editorial promise

Every date above traces to a primary source listed below. Proposed lists are labelled proposed; nothing here says “licence” where none exists. When the red-tier consultation, the English secondary legislation or the Scottish commencement orders land, this page changes the same week. That’s what the review date is for.

Frequently asked questions

No. As of 10 July 2026 there is no licence and no statutory minimum qualification in England. The government confirmed the scheme’s architecture in August 2025, but the follow-up consultation on highest-risk procedures had not been published by July 2026 and secondary legislation follows that. Realistic rollout is 2027 or later.